https://announcements.raceoncology.com/activity-updates/mst-access-research-report-september-2024
MST Access research report September 2024MST Access Senior Life Sciences Analyst Chris Kallos published the latest research report on Race Oncology, noting an improved valuation of the company at A$6.37 (prev. A$3.22) based on three key highlights post Race's full year reporting:
RAC - Charts & Price Action, page-22460
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.78 |
Change
0.005(0.28%) |
Mkt cap ! $305.9M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.80 | $1.78 | $75.36K | 42.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3445 | $1.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.80 | 4258 | 1 |
View Market Depth
| Last trade - 13.52pm 30/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |